Simulations Plus: Better Quarter, Same Doubts

Simulations Plus remains rated Hold as 8% YoY Q2 2026 revenue growth to $24.3M and a 91% software renewal rate were not enough to justify a Buy. Services backlog rose 18% YoY, but the stock still screens expensive on GAAP metrics despite trading at about 14x blended earnings. The overall read is cautious: business is stabilizing, but growth in revenue and cash flow remains too slow for a more constructive stance.

Analysis

SLP looks like a classic “cheap for a reason” setup: the market is rewarding stabilization, but not yet underwriting a re-acceleration in the earnings engine. The important second-order read-through is that software retention and backlog growth protect near-term visibility, yet they do little for multiple expansion if investors continue to see the business as a low-growth compounder with limited operating leverage. That leaves the stock vulnerable to any disappointment in conversion of backlog into revenue or margin expansion over the next 1-2 quarters.

The competitive dynamic is subtle: if renewal rates are holding, the company is likely defending its installed base rather than taking share aggressively. That implies competitors may be more exposed in new-logo acquisition and pricing pressure, but the larger market signal is that buyers are still willing to maintain mission-critical spend while delaying discretionary expansion. In practice, that favors larger platform vendors with broader suites and greater cross-sell ability, while smaller adjacent software names with weaker retention could see valuation dispersion widen.

The main catalyst window is the next 2 earnings prints. A move from stabilization to real upside would require either sustained backlog conversion or evidence that services demand is translating into higher-quality recurring revenue, not just one-time project work. Absent that, the risk is that the stock remains range-bound: headline multiple looks optically inexpensive, but GAAP economics and cash conversion keep institutional buyers on the sidelines.

Consensus may be underestimating how little it takes for this name to re-rate in either direction. Because expectations are already muted, incremental upside is possible if management shows even modest operating leverage; but the more likely asymmetry is downside if growth slips from high-single digits to mid-single digits, since the market will likely compress the multiple before the fundamentals visibly roll over.

Key Decisions for Investors

• Maintain Hold / no new long ahead of the next earnings cycle; the setup needs evidence of conversion, not just stabilization. Risk/reward is poor until revenue growth or cash flow inflects, with 10-15% downside if the market re-rates the stock back toward a lower GAAP multiple.
• Use strength to trim or hedge existing exposure with a 1-2 quarter horizon; the stock can stay cheap for months if operating leverage remains absent. A covered-call overlay makes sense if shares bounce on sentiment rather than fundamentals.
• For a relative-value expression, pair long higher-quality recurring software names against SLP if you want to own software beta while avoiding a low-conviction compounder. The trade benefits if the market continues to reward retention-heavy platforms over slower growers.
• If you want optionality, consider a small starter long only on a post-earnings pullback with a hard stop on evidence that renewal rates or backlog growth are not converting into better cash flow. The attractive entry is after disappointment, not before confirmation.